137 related articles for article (PubMed ID: 14550706)
1. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
Yau T; Epstein RJ
Lancet; 2003 Oct; 362(9390):1154-5; author reply 1155-6. PubMed ID: 14550706
[No Abstract] [Full Text] [Related]
2. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
Cunnick GH; Mokbel K
Lancet; 2003 Oct; 362(9390):1154; author reply 1155-6. PubMed ID: 14550707
[No Abstract] [Full Text] [Related]
3. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
Zammit C; Yelland A; Deutsch G
Lancet; 2003 Oct; 362(9390):1154; author reply 1155-6. PubMed ID: 14550708
[No Abstract] [Full Text] [Related]
4. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
Baroni G; Pedotti A; Orecchia R
Lancet; 2003 Oct; 362(9390):1155; author reply 1155-6. PubMed ID: 14550709
[No Abstract] [Full Text] [Related]
5. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
Tjalma WA
Lancet; 2003 Oct; 362(9390):1156-7. PubMed ID: 14550711
[No Abstract] [Full Text] [Related]
6. Is radiotherapy boost needed in young patients with ductal carcinoma-in-situ?
Wong JS
Lancet Oncol; 2006 Aug; 7(8):615-7. PubMed ID: 16887475
[No Abstract] [Full Text] [Related]
7. Non-surgical management of early breast cancer in the United Kingdom: ductal carcinoma in situ. Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology.
Spittle M; Stewart HJ
Clin Oncol (R Coll Radiol); 1995; 7(4):217-8. PubMed ID: 8845314
[TBL] [Abstract][Full Text] [Related]
8. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
Yen TW; Kuerer HM; Ottesen RA; Rouse L; Niland JC; Edge SB; Theriault RL; Weeks JC
J Clin Oncol; 2007 Aug; 25(22):3251-8. PubMed ID: 17577019
[TBL] [Abstract][Full Text] [Related]
9. Ductal carcinoma in situ--current management.
O'Sullivan MJ; Morrow M
Surg Clin North Am; 2007 Apr; 87(2):333-51, viii. PubMed ID: 17498530
[TBL] [Abstract][Full Text] [Related]
10. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen in ductal carcinoma in situ.
Daly MB
Semin Oncol; 2006 Dec; 33(6):647-9. PubMed ID: 17145343
[TBL] [Abstract][Full Text] [Related]
12. The role of radiation therapy after local excision of invasive and noninvasive breast cancer.
Marks LB; Prosnitz LR
Surg Oncol Clin N Am; 1997 Apr; 6(2):359-79. PubMed ID: 9115501
[TBL] [Abstract][Full Text] [Related]
13. [Local recurrence of ductal in situ carcinoma of the breast].
Dunst J
Strahlenther Onkol; 1999 Jul; 175(7):348-9. PubMed ID: 10432998
[No Abstract] [Full Text] [Related]
14. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial.
Houghton J; George WD; Cuzick J; Duggan C; Fentiman IS; Spittle M; ; ;
Lancet; 2003 Jul; 362(9378):95-102. PubMed ID: 12867108
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.
Overgaard M; Jensen MB; Overgaard J; Hansen PS; Rose C; Andersson M; Kamby C; Kjaer M; Gadeberg CC; Rasmussen BB; Blichert-Toft M; Mouridsen HT
Lancet; 1999 May; 353(9165):1641-8. PubMed ID: 10335782
[TBL] [Abstract][Full Text] [Related]
16. [Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853].
Noël G; Mazeron JJ
Cancer Radiother; 2001 Apr; 5(2):193-4. PubMed ID: 11355583
[No Abstract] [Full Text] [Related]
17. Ductal carcinoma in situ.
Venniyoor A
Aust Fam Physician; 2006 May; 35(5):278-9; author reply 279. PubMed ID: 16708448
[No Abstract] [Full Text] [Related]
18. Breast cancer (non-metastatic).
Dixon JM; Rodger A; Stebbing J
Clin Evid; 2005 Jun; (13):2226-57. PubMed ID: 16135326
[No Abstract] [Full Text] [Related]
19. [Ductal in situ carcinoma: is it ethical to consider the breast conserving therapy as a standard?].
Barillot I; Cutuli B; Arnould L
Cancer Radiother; 2004 Feb; 8(1):9-20. PubMed ID: 15093196
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer (non-metastatic).
Rodger A; Stebbing J; Thompson AM
Clin Evid; 2006 Jun; (15):2360-92. PubMed ID: 16973090
[No Abstract] [Full Text] [Related]
[Next] [New Search]